MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1009-1016

  Zhou, Lin ^a   He, Jiantai ^a   Zhang, Yangde ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

clinicopathological features; ezrin; Hepatocellular carcinoma; miR 22; prognosis

Indexed keywords

EZRIN; MICRORNA 22;

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE DIFFERENTIATION;

EID: 84887332022     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513484436     Document Type: Article

References (33)

1. Winter J,Jung S,Keller S,et al.Many roads to maturity: microRNA biogenesis pathways and their regulation.Nat Cell Biol. 2009;11:228-234.
2. Krol J,Loedige I,Filipowicz W.The widespread regulation of microRNA biogenesis, function and decay.Nat Rev Genet. 2010;11:597-610.
3. Kertesz M,Iovino N,Unnerstall U,et al.The role of site accessibility in microRNA target recognition.Nat Genet. 2007;39:1278-1284.
4. Jackson AL,Linsley PS.Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.Nat Rev Drug Discov. 2010;9:57-67.
5. Baffa R,Fassan M,Volinia S,et al.MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.J Pathol. 2009;219:214-221.
6. Calin GA,Croce CM.MicroRNA-cancer connection: the beginning of a new tale.Cancer Res. 2006;66:7390-7394.
7. Nevins JR,Potti A.Mining gene expression profiles: expression signatures as cancer phenotypes.Nat Rev Genet. 2007;8:601-609.
8. Kumar MS,Lu J,Mercer KL,et al.Impaired microRNA processing enhances cellular transformation and tumorigenesis.Nat Genet. 2007;39:673-677.
9. Zhao H,Guo M,Zhao G,et al.miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.Int J Mol Med. 2012;30:1013-1020.
10. Wang G,Mao W,Zheng S.MicroRNA-183 regulates Ezrin expression in lung cancer cells.FEBS Lett. 2008;582:3663-3668.
11. Tio TL.The TNM staging system.Gastrointest Endosc. 1996;43:S19-24.
12. Kenmochi K,Sugihara S,Kojiro M.Relationship of his tologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.Liver. 1987;7:18-26.
13. Zhou L,Rui JA,Wang SB,et al.Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.J Surg Oncol. 2007;95:298-303.
14. Schöniger-Hekele M,Hänel S,Wrba F,et al.Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients.Liver Int. 2005;25:62-69.
15. He L,Hannon GJ.MicroRNAs: small RNAs with a big role in gene regulation.Nat Rev Genet. 2004;5:522-531.
16. Iorio MV,Carlo CM.MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.EMBO Mol Med. 2012;4:143-159.
17. Vasudevan S.Posttranscriptional upregulation by microRNAs.Wiley Interdiscip Rev RNA. 2012;3:311-330.
18. Ji J,Shi J,Budhu A,et al.MicroRNA expression, survival, and response to interferon in liver cancer.N Engl J Med. 2009;361:1437-1447.
19. Torres A,Torres K,Maciejewski R,et al.MicroRNAs and their role in gynecological tumors.Med Res Rev. 2011;31:895-923.
20. Vasilatou D,Papageorgiou S,Pappa V,et al.The role of microRNAs in normal and malignant hematopoiesis.Eur J Haematol. 2010;84:1-16.
21. Menéndez P,Villarejo P,Padilla D,et al.Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.J Surg Oncol. 2013;107:217-220.
22. Mott JL.MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia.Hepatology. 2009;50:630-637.
23. Tang Y,Chen J,Xiao J,et al.Expression of miRNA-22 during adipogenic differentiation process of adipose tissue-derived stromal cells in vitro.J Clin Rehabil Tissue Eng Res. 2009;13:412-418.
24. Yamakuchi M,Yagi S,Ito T,et al.MicroRNA-22 regulates hypoxia signaling in colon cancer cells.PLoS One. 2011;6:e20291-e20291.
25. Pandey DP,Picard D.MiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.Mol Cell Biol. 2009;29:3783-3790.
26. Li J,Liang S,Yu H,et al.An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer.Gynecol Oncol. 2010;119:543-548.
27. Liu L,Jiang Y,Zhang H,et al.miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.Toxicol In Vitro. 2010;24:1168-1175.
28. Louvet-Vallée S.ERM proteins: from cellular architecture to cell signaling.Biol Cell. 2000;92:305-316.
29. Kang YK,Hong SW,Lee H,et al.Prognostic implications of ezrin expression in human hepatocellular carcinoma.Mol Carcinog. 2010;49:798-804.
30. Yu Y,Khan J,Khanna C,et al.Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-l as key metastatic regulators.Nat Med. 2004;10:175-181.
31. Nowak D,Mazur AJ,Popow-Woźniak A,et al.Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential.Eur J Histochem. 2010;54:e14-e14.
32. Li X,Zhang Y,Zhang Y,et al.Survival prediction of gastric cancer by a seven-microRNA signature.Gut. 2010;59:579-585.
33. Patel JB,Appaiah HN,Burnett RM,et al.Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.Oncogene. 2011;30:1290-1301.